HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Y Hamamoto Selected Research
Y Hamamoto Research Topics
Disease
3
Type 2 Diabetes Mellitus (MODY)
05/2015 - 01/2006
2
Diabetes Mellitus
01/2018 - 01/2016
2
Infections
01/2018 - 03/2001
2
Pancreatic Neoplasms (Pancreatic Cancer)
06/2017 - 04/2015
2
Stomach Neoplasms (Stomach Cancer)
10/2013 - 01/2001
2
Neoplasms (Cancer)
09/2013 - 05/2000
2
Adenoma (Adenomas)
09/2013 - 12/2001
1
Necrosis
01/2018
1
Periodontitis
01/2018
1
Periodontal Diseases (Periodontal Disease)
01/2018
1
Rheumatoid Arthritis
01/2018
1
Bone Resorption
01/2018
1
Chickenpox
01/2016
1
Colorectal Neoplasms (Colorectal Cancer)
05/2015
1
Glucose Intolerance
11/2013
1
Acromegaly
11/2013
1
Insulin Resistance
11/2013
1
Atrophy
09/2013
1
Spinal Cord Injuries (Spinal Cord Injury)
02/2010
1
Spinal Cord Compression
02/2010
1
Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
01/2007
1
Lymphoma (Lymphomas)
01/2005
1
Craniopharyngioma (Craniopharyngiomas)
02/2002
1
Cysts
02/2002
1
Pathologic Constriction (Stenosis)
10/2001
1
Contracture
10/2001
1
Fibrosis (Cirrhosis)
10/2001
1
Urinary Bladder Neoplasms (Bladder Cancer)
10/2001
1
Hyperglycemia
09/2001
1
Dysuria
06/2001
1
Respiratory Tract Infections (Respiratory Tract Infection)
01/2001
1
Melanoma (Melanoma, Malignant)
01/2001
1
Neoplasm Metastasis (Metastasis)
01/2001
1
Drug Eruptions (Drug Eruption)
01/2001
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2001
1
Carcinoma (Carcinomatosis)
01/2001
1
Seborrheic Keratosis
12/2000
1
Priapism
12/2000
1
Amyloidosis
12/2000
1
Psoriatic Arthritis
12/2000
1
Amyloid Plaque
12/2000
Drug/Important Bio-Agent (IBA)
2
Gemcitabine
FDA Link
06/2017 - 04/2015
2
Creatinine
IBA
05/2015 - 04/2012
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
05/2015 - 04/2015
2
Pharmaceutical Preparations
IBA
01/2006 - 01/2000
2
Anti-Bacterial Agents (Antibiotics)
IBA
06/2001 - 01/2001
1
Messenger RNA (mRNA)
IBA
01/2018
1
Proteins (Proteins, Gene)
FDA Link
01/2018
1
Quercetin
IBA
01/2018
1
Antigens
IBA
01/2018
1
RNA-Binding Proteins (RNA-Binding Protein)
IBA
01/2018
1
Interleukin-6 (Interleukin 6)
IBA
01/2018
1
Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)
IBA
01/2016
1
23-valent pneumococcal capsular polysaccharide vaccine
IBA
01/2016
1
Herpes Zoster Vaccine
IBA
01/2016
1
Fluorouracil (Carac)
FDA Link
Generic
05/2015
1
Bevacizumab (Avastin)
FDA Link
05/2015
1
Irinotecan (Camptosar)
FDA Link
Generic
05/2015
1
Angiopoietin-Like Protein 8
IBA
05/2015
1
C-Peptide
IBA
05/2015
1
Leucovorin (Folinic Acid)
FDA Link
05/2015
1
Glucagon (Glukagon)
FDA Link
05/2015
1
Growth Hormone (Somatotropin)
IBA
11/2013
1
Insulin-Like Growth Factor I (IGF-1)
IBA
11/2013
1
Biomarkers (Surrogate Marker)
IBA
10/2013
1
Hydrocortisone (Cortisol)
FDA Link
Generic
09/2013
1
dehydroepiandrosterone sulfotransferase
IBA
09/2013
1
Aldosterone
IBA
09/2013
1
Albumins
IBA
04/2012
1
Alprostadil (Muse)
FDA Link
Generic
02/2010
1
Vasopressins (Vasopressin)
IBA
01/2007
1
Therapeutic Uses
IBA
01/2005
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2005
1
Methacrylates
IBA
10/2001
1
Insulin (Novolin)
FDA Link
09/2001
1
Interleukin-2 (IL2)
IBA
01/2001
1
Cytokines
IBA
01/2001
1
Clarithromycin (Biaxin)
FDA Link
Generic
01/2001
1
Macrolides
IBA
01/2001
1
Amyloid (Amyloid Fibrils)
IBA
12/2000
1
Monoclonal Antibodies
IBA
12/2000
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2000
1
Keratins (Keratin)
IBA
12/2000
1
Antibodies
IBA
12/2000
1
Amyloidogenic Proteins
IBA
12/2000
Therapy/Procedure
2
Operative Surgical Procedures
10/2001 - 05/2000
2
Therapeutics
12/2000 - 01/2000
1
Ligation
01/2018
1
Combination Drug Therapy (Combination Chemotherapy)
05/2015
1
Drug Therapy (Chemotherapy)
10/2013
1
Lasers (Laser)
02/2010
1
Conservative Treatment
02/2002
1
Radiotherapy
02/2002
1
Nephrectomy
12/2001
1
Cystectomy
10/2001
1
Urinary Diversion (Ileal Conduit)
10/2001
1
Transplantation
09/2001
1
Islets of Langerhans Transplantation
09/2001
1
Antibiotic Prophylaxis
03/2001
1
Intralesional Injections
01/2001